News You Can Use
Updates and news related to prostate cancer:
PSMA-PET Shows Diagnostic Accuracy in Initial Staging of Prostate Cancer
Findings from a recent study show that PSMA-PET may have diagnostic value in the initial staging of patients with intermediate- and high-risk prostate cancer.
Prolaris’ Value in Predicting Prostate Cancer Outcomes
The National Comprehensive Cancer Network (NCCN) has endorsed the Prolaris prostate cancer prognostic test, reinforcing its position as a critical tool in prostate cancer prognostication.
Role of Diet
Men on active surveillance who followed a low omega-6, high omega-3 diet with fish oil supplements had significantly lower levels of cancer cell proliferation after one year.
Use of Combination Therapies for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
A VA study examines outcomes in patients.
Germline Testing
A study's implications for veteran access to prostate cancer treatments
Advances in Metastatic Castration Resistant Prostate Cancer Management
Recent approvals, emerging therapies, and future directions
FDA Receives NDA for 3-Month Version of Leuprolide Mesylate for Advanced Prostate Cancer
The trial excluded patients with recent chemotherapy, immunotherapy, or major surgeries, ensuring a focused study population.
Exercise Benefits In Prostate Cancer Active Surveillance
Older Men Increasingly Overtreated for Prostate Cancer
VA analysis finds men with limited life expectancy still getting aggressive treatment.
Survival, Progression Improves With Xofigo Plus Xtandi for Certain Patients With Prostate Cancer
Patients with metastatic, castration-resistant prostate cancer saw significant benefits from the combination of Xofigo and Xtandi.